Karen E. Knudsen

Affiliations: 
University of Cincinnati, Cincinnati, OH 
Area:
Cell Biology, Oncology
Google:
"Karen Knudsen"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McNair C, Urbanucci A, Comstock CE, et al. (2016) Cell cycle-coupled expansion of AR activity promotes cancer progression. Oncogene
Kim H, Alshalalfa M, Hoffman-Censits J, et al. (2016) Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report Urology Case Reports. 9: 51-54
Schrecengost RS, Keller SN, Schiewer MJ, et al. (2015) Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression. Molecular Cancer Research : McR
Feng FY, de Bono JS, Rubin MA, et al. (2015) Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function. Molecular Cell. 58: 925-34
Hovelson DH, McDaniel AS, Cani AK, et al. (2015) Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors. Neoplasia (New York, N.Y.). 17: 385-99
Augello MA, Berman-Booty LD, Carr R, et al. (2015) Consequence of the tumor-associated conversion to cyclin D1b. Embo Molecular Medicine. 7: 628-47
Prensner JR, Chen W, Han S, et al. (2014) The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia (New York, N.Y.). 16: 900-8
Jimbo M, Knudsen KE, Brody JR. (2014) Fusing transcriptomics to progressive prostate cancer. The American Journal of Pathology. 184: 2608-10
Den RB, Feng FY, Showalter TN, et al. (2014) Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 89: 1038-46
Dressing GE, Knutson TP, Schiewer MJ, et al. (2014) Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 28: 442-57
See more...